Shawn E. Stovall
Fondateur chez Sontra Medical, Inc.
Profil
Shawn E.
Stovall is Chief Operating Officer of Palmett Pharmaceuticals, Inc. He is Founder of Reprogenesis, Inc. and Sontra Medical, Inc. Mr. Stovall received an undergraduate degree from Southern Methodist University.
Postes actifs de Shawn E. Stovall
| Sociétés | Poste | Début |
|---|---|---|
| Sontra Medical, Inc. | Fondateur | 26/10/2009 |
Anciens postes connus de Shawn E. Stovall
| Sociétés | Poste | Fin |
|---|---|---|
Enos Pharmaceuticals, Inc.
 Enos Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Palmetto Pharmaceuticals LLC, Enos Pharmaceuticals, Inc. develops pharmaceutical products. The company is based in Lexington, MA. The company was founded by James R. McNab, Alexander M. Klibanov. | Directeur des opérations | 07/07/2010 |
Reprogenesis, Inc.
 Reprogenesis, Inc. BiotechnologyHealth Technology Reprogenesis, Inc., located in Cambridge, Massachusetts developes tissue engineered therapies to treat unmet medical needs. The Company has proprietary technology utilizing the combination of cells and biomaterials to restore, repair or replace lost tissue or physiological function. The Company has a broad preclinical and clinical pipeline of products in the areas of urology, cardiovascular biology and plastic and reconstructive surgery. ChondrogelTM is its most advanced product | Fondateur | 06/11/2008 |
Formation de Shawn E. Stovall
| Southern Methodist University | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Enos Pharmaceuticals, Inc.
Enos Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Palmetto Pharmaceuticals LLC, Enos Pharmaceuticals, Inc. develops pharmaceutical products. The company is based in Lexington, MA. The company was founded by James R. McNab, Alexander M. Klibanov. | Health Technology |
Reprogenesis, Inc.
Reprogenesis, Inc. BiotechnologyHealth Technology Reprogenesis, Inc., located in Cambridge, Massachusetts developes tissue engineered therapies to treat unmet medical needs. The Company has proprietary technology utilizing the combination of cells and biomaterials to restore, repair or replace lost tissue or physiological function. The Company has a broad preclinical and clinical pipeline of products in the areas of urology, cardiovascular biology and plastic and reconstructive surgery. ChondrogelTM is its most advanced product | Health Technology |
| Sontra Medical, Inc. |
